Evidence map›Paper›PMID 32938694›Full record

ArticlemSphere2020

Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland.

Margherita Bodini, Alessandro Brozzi, Maria Giuliani, Hanna Nohynek, Anni Vainio, Markku Kuusi, Rosita De Paola, Mariagrazia Pizza, Duccio Medini, Maija Toropainen and 2 more

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Genomic characterization of invasiveEmerging microbes & infections · 2025
    Article
  3. Review
  4. 4CMenB journey to the 10-year anniversary and beyond.Human vaccines & immunotherapeutics · 2024
    Review
  5. Article
  6. Article
  7. Molecular characterization of invasiveFrontiers in cellular and infection microbiology · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Margherita BodiniGSK, Siena, Italy.
Alessandro BrozziGSK, Siena, Italy.
Maria GiulianiGSK, Siena, Italy.
Hanna NohynekFinnish Institute for Health and Welfare (THL), Helsinki, Finland.
Anni VainioFinnish Institute for Health and Welfare (THL), Helsinki, Finland.
Markku KuusiFinnish Institute for Health and Welfare (THL), Helsinki, Finland.
Rosita De PaolaGSK, Siena, Italy.
Mariagrazia PizzaGSK, Siena, Italy.
Duccio MediniGSK, Siena, Italy.
Maija ToropainenFinnish Institute for Health and Welfare (THL), Helsinki, Finland.
Laura SerinoGSK, Siena, Italy.
Alessandro MuzziGSK, Siena, Italy alessandro.x.muzzi@gsk.com.ORCID 0000-0002-8635-6424
Finnish Institute for Health and Welfare · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive meningococcal disease (IMD) caused by

Indexed as

Genetic VariationAntigens, BacterialBacterial Typing TechniquesEpidemiological MonitoringFinlandGenomicsHumansMeningococcal VaccinesMultilocus Sequence TypingNeisseria meningitidis, Serogroup BPhylogenyVaccination CoverageWhole Genome Sequencing4CMenB vaccineAntigens, BacterialMeningococcal Vaccines4CMenBantigen typing systemgenomicsgMATSMATSmeningococcal diseasevaccine coverage

Identifiers

PMID32938694
PMCPMC7494829
OpenAlexW3087593997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.